RNA-Mediated Gene Silencing of Nicotinamide N-Methyltransferase Is Associated with Decreased Tumorigenicity in Human Oral Carcinoma Cells

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Pozzi, Valentina ^a   Sartini, Davide ^a   Morganti, Stefano ^a   Giuliante, Rachela ^a   Di Ruscio, Giulia ^a   Santarelli, Andrea ^a,b   Rocchetti, Romina ^a   Rubini, Corrado ^a   Tomasetti, Marco ^a   Giannatempo, Giovanni ^c   Orlando, Fiorenza ^b   Provinciali, Mauro ^b   Muzio, Lorenzo Lo ^c   Emanuelli, Monica ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b INRCA   (Italy)

^c UNIVERSITY OF FOGGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINAMIDE METHYLTRANSFERASE; SHORT HAIRPIN RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER INHIBITION; CARCINOGENICITY; CELL METABOLISM; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; GENE SILENCING; GENE TARGETING; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; MALE; MOUSE; MOUTH CARCINOMA; NONHUMAN; PROTEIN FUNCTION; RNA INTERFERENCE; TUMOR GROWTH; TUMOR VOLUME;

AGAR; ANIMALS; BLOTTING, WESTERN; CARCINOMA; CELL LINE, TUMOR; CELL PROLIFERATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; GENE SILENCING; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MOUTH NEOPLASMS; NEOPLASM TRANSPLANTATION; NICOTINAMIDE N-METHYLTRANSFERASE; REAL-TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA, SMALL INTERFERING; TETRAZOLIUM SALTS; THIAZOLES; TUMOR MARKERS, BIOLOGICAL;

EID: 84882731930     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0071272     Document Type: Article

References (45)

1. Xiong P, Li YX, Tang YT, Chen HG, (2011) Proteomic analyses of Sirt1-mediated cisplatin resistance in OSCC cell line. Protein J 30 (7) (): 499-508.
2. Wu JY, Yi C, Chung HR, Wang DJ, Chang WC, et al. (2010) Potential biomarkers in saliva for oral squamous cell carcinoma. Oral Oncol 46 (4) (): 226-31.
3. Aksoy S, Szumlanski CL, Weinshilboum RM, (1994) Human liver nicotinamide N-methyltransferase. cDNA cloning, expression, and biochemical characterization. J Biol Chem 269 (20) (): 14835-40.
4. Peng Y, Sartini D, Pozzi V, Wilk D, Emanuelli M, et al. (2011) Structural basis of substrate recognition in human nicotinamide N-methyltransferase. Biochemistry 50 (36) (): 7800-8.
5. Sartini D, Muzzonigro G, Milanese G, Pierella F, Rossi V, et al. (2006) Identification of nicotinamide N-methyltransferase as a novel tumor marker for renal clear cell carcinoma. J Urol 176 (5) (): 2248-54.
6. Sartini D, Santarelli A, Rossi V, Goteri G, Rubini C, et al. (2007) Nicotinamide N-methyltransferase upregulation inversely correlates with lymph node metastasis in oral squamous cell carcinoma. Mol Med 13 (7-8) (): 415-21.
7. Emanuelli M, Santarelli A, Sartini D, Ciavarella D, Rossi V, et al. (2010) Nicotinamide N-Methyltransferase upregulation correlates with tumour differentiation in oral squamous cell carcinoma. Histol Histopathol 25 (1) (): 15-20.
8. Sartini D, Pozzi V, Renzi E, Morganti S, Rocchetti R, et al. (2012) Analysis of tissue and salivary nicotinamide N-methyltransferase in oral squamous cell carcinoma: basis for the development of a noninvasive diagnostic test for early-stage disease. Biol Chem 393 (6) (): 505-11.
9. Sartini D, Muzzonigro G, Milanese G, Pozzi V, Vici A, et al. (2012) Upregulation of Tissue and Urinary Nicotinamide N-Methyltransferase in Bladder Cancer: Potential for the Development of a Urine-Based Diagnostic Test. Cell Biochem Biophys 65 (3) (): 473-83.
10. Sartini D, Morganti S, Guidi E, Rubini C, Zizzi A, et al. (2013) Nicotinamide N-methyltransferase in Non-small Cell Lung Cancer: Promising Results for Targeted Anti-cancer Therapy. Cell Biochem Biophys Mar 27(Epub ahead of print).
11. Pozzi V, Mazzotta M, Lo Muzio L, Sartini D, Santarelli A, et al. (2011) Inhibiting proliferation in KB cancer cells by RNA interference-mediated knockdown of nicotinamide N-methyltransferase expression. Int J Immunopathol Pharmacol 24 (1) (): 69-77.
12. Bradford MM, (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-54.
13. Balducci E, Orsomando G, Polzonetti V, Vita A, Emanuelli M, et al. (1995) NMN adenylyltransferase from bull testis: purification and properties. Biochem J 310 (Pt 2) (): 395-400.
14. Lo Muzio L, Sartini D, Santarelli A, Rocchetti R, Morganti S, et al. (2012) Expression and prognostic significance of apoptotic genes in oral squamous cell carcinoma. Mol Carcinog doi: 10.1002/mc.21960.
15. Okamoto H, Ishikawa A, Yoshitake Y, Kodama N, Nishimuta M, et al. (2003) Diurnal variations in human urinary excretion of nicotinamide catabolites: effects of stress on the metabolism of nicotinamide. Am J Clin Nutr 77: 406-10.
16. Markert JM, Fuller CM, Gillespie GY, Bubien JK, McLean LA, et al. (2001) Differential gene expression profiling in human brain tumors. Physiol Genomics 5 (1) (): 21-33.
17. Jang JS, Cho HY, Lee YJ, Ha WS, Kim HW, (2004) The differential proteome profile of stomach cancer: identification of the biomarker candidates. Oncol Res 14 (10) (): 491-499.
18. Lim BH, Cho BI, Kim YN, Kim JW, Park ST, et al. (2006) Overexpression of nicotinamide N-methyltransferase in gastric cancer tissues and its potential post-translational modification. Exp Mol Med 38 (5) (): 455-65.
19. Xu J, Moatamed F, Caldwell JS, Walker JR, Kraiem Z, et al. (2003) Enhanced expression of nicotinamide N-methyltransferase in human papillary thyroid carcinoma cells. J Clin Endocrinol Metab 88 (10) (): 4990-4996.
20. Xu J, Capezzone M, Xu X, Hershman JM, (2005) Activation of nicotinamide N-methyltransferase gene promoter by hepatocyte nuclear factor-1beta in human papillary thyroid cancer cells. Mol Endocrinol 19 (2) (): 527-539.
21. Yao M, Tabuchi H, Nagashima Y, Baba M, Nakaigawa N, et al. (2005) Gene expression analysis of renal carcinoma: adipose differentiation-related protein as a potential diagnostic and prognostic biomarker for clear-cell renal carcinoma. J Pathol 205: 377-87.
22. Roessler M, Rollinger W, Palme S, Hagmann ML, Berndt P, et al. (2005) Identification of nicotinamide N-methyltransferase as a novel serum tumor marker for colorectal cancer. Clin Cancer Res 11: 6550-7.
23. Tomida M, Mikami I, Takeuchi S, Nishimura H, Akiyama H, (2009) Serum levels of nicotinamide N-methyltransferase in patients with lung cancer. J Cancer Res Clin Oncol 135 (9) (): 1223-1229.
24. Rogers CD, Fukushima N, Sato N, Shi C, Prasad N, et al. (2006) Differentiating pancreatic lesions by microarray and QPCR analysis of pancreatic juice RNAs. Cancer Biol Ther 5 (10) (): 1383-1389.
25. Kim J, Hong SJ, Lim EK, Yu YS, Kim SW, et al. (2009) Expression of nicotinamide N-methyltransferase in hepatocellular carcinoma is associated with poor prognosis. J Exp Clin Cancer Res 16: 28: 20.
26. Mateuszuk Ł, Khomich TI, Słomińska E, Gajda M, Wójcik L, et al. (2009) Activation of nicotinamide N-methyltrasferase and increased formation of 1-methylnicotinamide (MNA) in atherosclerosis. Pharmacol Rep 61 (1) (): 76-85.
27. Debigaré R, Maltais F, Côté CH, Michaud A, Caron MA, et al. (2008) Profiling of mRNA expression in quadriceps of patients with COPD and muscle wasting. COPD 5: 75-84.
28. Savarimuthu Francis SM, Larsen JE, Pavey SJ, Duhig EE, Clarke B, et al. (2011) Genes and gene ontologies common to airflow obstruction and emphysema in the lungs of patients with COPD. PLoS One 6 (3) (): e17442.
29. Williams AC, Ramsden DB, (2005) Autotoxicity, methylation and a road to the prevention of Parkinson's disease. J Clin Neurosci 12: 6-11.
30. Szakács G, Annereau JP, Lababidi S, Shankavaram U, Arciello A, et al. (2004) Predicting drug sensitivity and resistance: profiling ABC transporter genes in cancer cells. Cancer Cell 6 (2) (): 129-37.
31. Wu Y, Siadaty MS, Berens ME, Hampton GM, Theodorescu D, (2008) Overlapping gene expression profiles of cell migration and tumor invasion in human bladder cancer identify metallothionein 1E and nicotinamide N-methyltransferase as novel regulators of cell migration. Oncogene 27: 6679-89.
32. Kim HC, Mofarrahi M, Vassilakopoulos T, Maltais F, Sigala I, et al. (2010) Expression and functional significance of nicotinamide N-methyl transferase in skeletal muscles of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 181 (8) (): 797-805.
33. Parsons RB, Aravindan S, Kadampeswaran A, Evans EA, Sandhu KK, et al. (2011) The expression of nicotinamide N-methyltransferase increases ATP synthesis and protects SH-SY5Y neuroblastoma cells against the toxicity of Complex I inhibitors. Biochem J 436: 145-55.
34. Tang SW, Yang TC, Lin WC, Chang WH, Wang CC, et al. (2011) Nicotinamide N-methyltransferase induces cellular invasion through activating matrix metalloproteinase-2 expression in clear cell renal cell carcinoma cells. Carcinogenesis 32: 138-45.
35. Zhang J, (2003) Are poly(ADP-ribosyl)ation by PARP-1 and deacetylation by Sir2 linked? Bioessays 25: 808-14.
36. Kassem HSh, Sangar V, Cowan R, Clarke N, Margison GP, (2002) A potential role of heat shock proteins and nicotinamide N-methyl transferase in predicting response to radiation in bladder cancer. Int J Cancer 101: 454-60.
37. D'Andrea FP, Safwat A, Kassem M, Gautier L, Overgaard J, et al. (2011) Cancer stem cell overexpression of nicotinamide N-methyltransferase enhances cellular radiation resistance. Radiother Oncol 99: 373-8.
38. Audrito V, Vaisitti T, Rossi D, Gottardi D, D'Arena G, et al. (2011) Nicotinamide blocks proliferation and induces apoptosis of chronic lymphocytic leukemia cells through activation of the p53/miR-34a/SIRT1 tumor suppressor network. Cancer Res 71: 4473-8.
39. Chlopicki S, Swies J, Mogielnicki A, Buczko W, Bartus M, et al. (2007) (1-Methylnicotinamide (MNA), a primary metabolite of nicotinamide, exerts anti-thrombotic activity mediated by a cyclooxygenase-2/prostacyclin pathway. Br J Pharmacol 152: 230-9.
40. Bartuś M, Łomnicka M, Kostogrys RB, Kaźmierczak P, Watała C, et al. (2008) 1-Methylnicotinamide (MNA) prevents endothelial dysfunction in hypertriglyceridemic and diabetic rats. Pharmacol Rep 60: 127-38.
41. Brzozowski T, Konturek PC, Chlopicki S, Sliwowski Z, Pawlik M, et al. (2008) Therapeutic potential of 1-methylnicotinamide against acute gastric lesions induced by stress: role of endogenous prostacyclin and sensory nerves. J Pharmacol Exp Ther 326: 105-16.
42. Bryniarski K, Biedron R, Jakubowski A, Chlopicki S, Marcinkiewicz J, (2008) Anti-inflammatory effect of 1-methylnicotinamide in contact hypersensitivity to oxazolone in mice; involvement of prostacyclin. Eur J Pharmacol 578: 332-8.
43. Xu J, Capezzone M, Xu X, Hershman JM, (2005) Activation of nicotinamide N-methyltransferase gene promoter by hepatocyte nuclear factor-1beta in human papillary thyroid cancer cells. Mol Endocrinol 19: 527-39.
44. Xu J, Hershman JM, (2006) Histone deacetylase inhibitor depsipeptide represses nicotinamide N-methyltransferase and hepatocyte nuclear factor-1beta gene expression in human papillary thyroid cancer cells. Thyroid 16: 151-60.
45. Tomida M, Ohtake H, Yokota T, Kobayashi Y, Kurosumi M, (2007) Stat3 up-regulates expression of nicotinamide N-methyltransferase in human cancer cells. J Cancer Res Clin Oncol 134: 551-9.